Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Piramal invests in UK drug chemical facilities

by Rick Mullin
February 11, 2022 | A version of this story appeared in Volume 100, Issue 6

 

Piramal Pharma Solutions plans to spend $61 million to expand its antibody-drug conjugate (ADC) facility in Grangemouth, Scotland. The drug services company says the project will begin with the addition of two ADC production suites next year. A sterile fill-and-finish facility and two additional large-scale production suites are planned. The company is also investing $14 million in equipment, infrastructure, and utility improvements at its active pharmaceutical ingredient plant in Morpeth, England.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.